Search

everythinglearnresearchcommunity

for

Search:↓

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

lncRNAs are important for understanding and treating skin diseases.

Isotretinoin can cause hair loss, and reducing the dose or using supplements like vitamin D and iron may help.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib is effective and safe for treating severe alopecia areata.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Dupilumab helps children with alopecia areata regrow hair safely.

The summit aimed to speed up finding treatments for alopecia areata.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

New alopecia treatments aim for better results and fewer side effects.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

New treatments offer hope for better managing hidradenitis suppurativa.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

The document is a detailed medical reference on skin and genetic disorders.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.